Hepatitis C Anti-HCV Screening

The Hepatitis C Anti-HCV Screening is used to detect antibodies produced by the immune system in response to the Hepatitis C virus (HCV). Because Hepatitis C is often a silent infection—frequently showing no symptoms for years while causing progressive liver damage—this screening is essential for early intervention. Identifying the virus early allows healthcare providers to monitor liver health and initiate highly effective antiviral treatments that can now cure the majority of cases, significantly reducing the long-term risk of cirrhosis, liver failure, and liver cancer. Furthermore, knowing the actual status is a critical step in preventing the accidental transmission of the virus to others.